13F filing recap · Q1 2026
What did Hillman Capital Management buy in Q1 2026?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every Hillman account, including accounts that belong to no fund below.
Stock value
$144.00M
Positions
56
Estimated turnover
25.0%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Hillman Capital Management opened new positions in Oracle, Intuit, Clorox, ServiceNow, Costar Group, and an iShares fund, while exiting Anheuser-Busch Inbev, Exxon Mobil, Microchip Technology, Nucor, the SPDR S&P 500 ETF, and ASML Holding. Notable increases included Fiserv and Adobe, both raised dramatically, along with moderate additions to Zimmer Biomet, Brown-Forman, Kraft Heinz, and Equifax. The firm trimmed DuPont, GSK, Boeing, Taiwan Semiconductor, Akamai, and Hershey, among others.